Randomized Phase II Trial of Adjuvant Hepatic Arterial Infusion and Systemic Chemotherapy With or Without Bevacizumab in Patients With Resected Hepatic Metastases From Colorectal Cancer

Documenti analoghi

• Updated long-term survival for patients with metastatic colorectal cancer treated with liver resection followed by hepatic arterial infusion and systemic chemotherapy: Survival for resected liver metastases
  di: Kemeny, Nancy E., et al.
  Pubblicazione: (2016)
• Conversion to Resectability Using Hepatic Artery Infusion Plus Systemic Chemotherapy for the Treatment of Unresectable Liver Metastases From Colorectal Carcinoma
  di: Kemeny, Nancy E., et al.
  Pubblicazione: (2009)
• Phase II trial of hepatic artery infusional and systemic chemotherapy for patients with unresectable hepatic metastases from colorectal cancer: Conversion to resection and long-term outcomes
  di: D’Angelica, Michael I., et al.
  Pubblicazione: (2015)
• KRAS Mutation Influences Recurrence Patterns in Patients Undergoing Hepatic Resection of Colorectal Metastases
  di: Kemeny, Nancy E., et al.
  Pubblicazione: (2014)
• Addition of Adjuvant Hepatic Artery Infusion to Systemic Chemotherapy Following Resection of Colorectal Liver Metastases Is Associated with Reduced Liver-Related Mortality
  di: Srouji, Rami, et al.
  Pubblicazione: (2020)